Skip to content

Author

Xi Wang

We have 2 of 5 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Recent Advances in Nanotechnology for Targeted Protein Degradation.

Mutations or overexpression of proteins contribute to the pathogenesis and progression of numerous diseases, including cancers and neurodegenerative disorders. Traditional small-molecule inhibitors have played a crucial role in treating these diseases; however, they still face several limitations, such as off-target to...

Meng-Chen Xu, Yi Y. Yang, Jia-Jing Chen et al. · 0 citations
Open access Aug 2026

αHSA-proIL-12: A Tumor-Conditional IL-12 Prodrug with Reduced Systemic Toxicity and Potent Antitumor Activity

Interleukin-12 (IL-12) potently promotes the recruitment and activation of immune cells within the tumor microenvironment (TME), highlighting its immense potential for cancer therapy. However, its dose-limiting systemic toxicity and short half-life severely hinder its clinical translation. Here, we design a tumor-condi...

Xi Wang, Liu Yang, Yu-Hao Hou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.